Dose adjustment in renal impairment
Dose adjustment may be needed in kidney disease.
Medicine information TIGECICLINA APTAPHARMA 50mg powder for solution for infusion
- Product code:
- W70394001
- Quantity:
- 10
- Pack volume:
- 10 ml
- Indicated for:
- bacterial infections
- Route of administration:
- infusion
- Substance:
- tigecycline (tetracycline antibiotic)
- ATC
- J01AA12 — Antiinfectives for systemic use | Tetracyclines
Tigecycline is an antibiotic from the glycylcycline class used for the treatment of complicated bacterial infections, including intra-abdominal infections, skin and soft tissue infections, and hospital-acquired pneumonia. It works by inhibiting bacterial protein synthesis and has a broad spectrum of activity against gram-positive, gram-negative, and anaerobic bacteria.
The medication is administered intravenously, as directed by a doctor, and the dosage is adjusted based on the severity of the infection and the patient's condition. It is primarily used for infections caused by bacteria resistant to other antibiotics.
Patients should be monitored for potential side effects, such as nausea, vomiting, diarrhea, or injection site reactions. It is important for patients to inform their doctor of any unusual symptoms.
Common side effects include nausea, vomiting, diarrhea, and abdominal pain. In rare cases, severe reactions such as pancreatitis or superinfections may occur. Patients should be informed of these risks before starting treatment.
The medication is administered intravenously, as directed by a doctor, and the dosage is adjusted based on the severity of the infection and the patient's condition. It is primarily used for infections caused by bacteria resistant to other antibiotics.
Patients should be monitored for potential side effects, such as nausea, vomiting, diarrhea, or injection site reactions. It is important for patients to inform their doctor of any unusual symptoms.
Common side effects include nausea, vomiting, diarrhea, and abdominal pain. In rare cases, severe reactions such as pancreatitis or superinfections may occur. Patients should be informed of these risks before starting treatment.
General data about TIGECICLINA APTAPHARMA 50mg
- Substance:
- tigecycline
- Date of latest medicines list:
- 01-08-2024
- Product code:
- W70394001
- Strength:
- 50mg
- Pharmaceutical form:
- powder for solution for infusion
- Pack volume:
- 10 ml
- Product type:
- Generic medicine
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Strengths available for tigecycline
- 10mg/ml
- 50mg
Official documents
Professional information (SmPC) - Romanian
Patient leaflet - Romanian
Packaging and labelling information - Romanian
The correspondence between the document and the displayed text is unconfirmed.
- Source institution
- ANMDMR
- Document language
- Romanian
Warnings:
Anaphylaxis
Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.
Colitis / severe diarrhea
Seek medical advice if severe or persistent diarrhea occurs.
Contraindicated in children
Do not give to children for whom it is contraindicated.
Avoid milk, calcium, iron, or antacids
Do not take with milk, calcium, iron, magnesium, or antacids if separation is recommended.
Photosensitivity
Avoid excessive exposure to sunlight or UV radiation.